Author

Ulrich-Frank Pape

EARLY RESPONSE TO GLEPAGLUTIDE, A NOVEL LONG-ACTING GLP-2 ANALOG, IN SHORT BOWEL SYNDROME PATIENTS WITH INTESTINAL FAILURE: RESULTS OF 24-WEEK PHASE 3 TRIAL
EARLY RESPONSE TO GLEPAGLUTIDE, A NOVEL LONG-ACTING GLP-2 ANALOG, IN SHORT BOWEL SYNDROME PATIENTS WITH INTESTINAL FAILURE: RESULTS OF 24-WEEK PHASE 3 TRIAL

Ulrich-Frank Pape  et al.

EVALUATION OF INTESTINAL PERMEABILITY TESTING AS BIOMARKER FOR ADAPTIVE RESPONSE IN SHORT BOWEL SYNDROME
EVALUATION OF INTESTINAL PERMEABILITY TESTING AS BIOMARKER FOR ADAPTIVE RESPONSE IN SHORT BOWEL SYNDROME

Ulrich-Frank Pape  et al.

Item 1 - 2 / 2
1